Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Medications

Mayo Clinic Minute: Statins plus lifestyle equals healthy life

Statins are medications that reduce your risk of a heart attack and stroke by lowering your cholesterol. Dr. Stephen Kopecky, a Mayo Clinic cardiologist, says people should combine statins with a heart-healthy lifestyle to ...

Cardiology

Many with atherosclerotic CVD not meeting LDL-C goals

(HealthDay)—A high proportion of patients with atherosclerotic cardiovascular disease (ASCVD) do not achieve recommended low-density lipoprotein cholesterol (LDL-C) goals, according to a study presented at the annual meeting ...

page 1 from 16